Furthermore, upregulation of gasdermine B (GSDMB), a member of the Gasdermin (GSDM) genes, in HER2 breast cancer promotes poor prognosis, aggressive, and resistant to anti-HER2 agents through elevating protective autophagy. The gene discussed is GSDMB; the disease is breast carcinoma.